CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 254 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,307,000 | +14.4% | 332,635 | +333.2% | 1.76% | +30.4% |
| Q2 2019 | $1,142,000 | -52.5% | 76,782 | -20.7% | 1.35% | -59.4% |
| Q1 2019 | $2,403,000 | +25.8% | 96,820 | -9.0% | 3.34% | +29.3% |
| Q4 2018 | $1,910,000 | -37.5% | 106,342 | +2.1% | 2.58% | -9.9% |
| Q3 2018 | $3,058,000 | -4.6% | 104,116 | +47.7% | 2.86% | -2.6% |
| Q2 2018 | $3,206,000 | +66.2% | 70,498 | +93.0% | 2.94% | +45.4% |
| Q1 2018 | $1,929,000 | +45.4% | 36,529 | +87.2% | 2.02% | +49.0% |
| Q4 2017 | $1,327,000 | -7.9% | 19,517 | +11.6% | 1.36% | -23.1% |
| Q3 2017 | $1,441,000 | +36.6% | 17,493 | +55.3% | 1.76% | +10.5% |
| Q2 2017 | $1,055,000 | +274.1% | 11,264 | -23.2% | 1.60% | +195.2% |
| Q1 2016 | $282,000 | – | 14,666 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |